Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HSAQ NYSE:NSPR NASDAQ:OBLN NASDAQ:PETV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSAQHealth Sciences Acquisitions Co. 2$3.85-3.0%$4.08$9.41▼$13.80$43.17M0.09205,918 shs479,402 shsNSPRInspireMD$0.74+3.6%$1.08$0.69▼$2.93$34.57M0.74182,198 shs44,799 shsOBLNObalon Therapeutics$2.13+0.9%$4.22$0.66▼$10.77$21.35M-1.237.68 million shs12,576 shsPETVPetVivo$0.80-6.0%$0.78$0.60▼$1.69$30.96M1.2510,834 shs19,194 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSAQHealth Sciences Acquisitions Co. 2-3.02%-4.47%+3.49%-14.63%+13.91%NSPRInspireMD+3.59%-4.82%-29.71%-56.84%-69.38%OBLNObalon Therapeutics0.00%0.00%0.00%+2.40%-25.78%PETVPetVivo-6.00%-0.09%+9.15%+1.14%+14.14%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHSAQHealth Sciences Acquisitions Co. 2$3.85-3.0%$4.08$9.41▼$13.80$43.17M0.09205,918 shs479,402 shsNSPRInspireMD$0.74+3.6%$1.08$0.69▼$2.93$34.57M0.74182,198 shs44,799 shsOBLNObalon Therapeutics$2.13+0.9%$4.22$0.66▼$10.77$21.35M-1.237.68 million shs12,576 shsPETVPetVivo$0.80-6.0%$0.78$0.60▼$1.69$30.96M1.2510,834 shs19,194 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHSAQHealth Sciences Acquisitions Co. 2-3.02%-4.47%+3.49%-14.63%+13.91%NSPRInspireMD+3.59%-4.82%-29.71%-56.84%-69.38%OBLNObalon Therapeutics0.00%0.00%0.00%+2.40%-25.78%PETVPetVivo-6.00%-0.09%+9.15%+1.14%+14.14%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHSAQHealth Sciences Acquisitions Co. 2 0.00N/AN/AN/ANSPRInspireMD 3.00Buy$4.50509.76% UpsideOBLNObalon Therapeutics 0.00N/AN/AN/APETVPetVivo 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest OBLN, HSAQ, NSPR, and PETV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/5/2026NSPRInspireMD Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$4.00 ➝ $3.005/4/2026NSPRInspireMD Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$4.00(Data available from 6/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/A($0.62) per shareN/ANSPRInspireMD$10.85M3.19N/AN/A$1.83 per share0.40OBLNObalon Therapeutics$1.59M13.43N/AN/A$0.60 per share3.55PETVPetVivo$1.05M27.82N/AN/A($0.03) per share-26.63Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHSAQHealth Sciences Acquisitions Co. 2-$380KN/AN/AN/AN/AN/AN/A-2.38%N/ANSPRInspireMD-$19.92M-$0.73N/AN/AN/A-413.96%-69.42%-57.68%N/AOBLNObalon Therapeutics-$12.33MN/AN/AN/AN/A-776.76%-161.38%-83.58%N/APETVPetVivo-$10.95M-$0.38N/AN/AN/A-902.82%-4,813.07%-281.78%6/25/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHSAQHealth Sciences Acquisitions Co. 2N/AN/AN/AN/AN/ANSPRInspireMDN/AN/AN/AN/AN/AOBLNObalon TherapeuticsN/AN/AN/AN/AN/APETVPetVivoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHSAQHealth Sciences Acquisitions Co. 2N/A0.170.61NSPRInspireMDN/A6.396.05OBLNObalon TherapeuticsN/A1.861.86PETVPetVivo0.020.420.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHSAQHealth Sciences Acquisitions Co. 289.71%NSPRInspireMD44.78%OBLNObalon Therapeutics18.64%PETVPetVivo24.55%Insider OwnershipCompanyInsider OwnershipHSAQHealth Sciences Acquisitions Co. 221.90%NSPRInspireMD34.06%OBLNObalon Therapeutics8.10%PETVPetVivo10.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHSAQHealth Sciences Acquisitions Co. 2411.21 million8.76 millionNot OptionableNSPRInspireMD5046.84 million18.33 millionOptionableOBLNObalon Therapeutics210.02 millionN/ANot OptionablePETVPetVivo2036.42 million19.06 millionNot OptionableOBLN, HSAQ, NSPR, and PETV HeadlinesRecent News About These CompaniesPetVivo Holdings, Inc. (PETV) Discusses Spryng Technology Adoption and Commercial Expansion in Veterinary Practice TranscriptJune 16 at 5:04 PM | seekingalpha.comPetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24thJune 16 at 1:30 PM | globenewswire.comPetVivo Holdings Selects New to The Street for National T.V. Commercials, the #1 New York City Market, Iconic Outdoor Advertising and Influencer ProgramJune 12, 2026 | finanznachrichten.dePetVivo Holdings (OTCQX:PETV) Selects New to The Street for National T.V. Commercials, the #1 New York City Market, Iconic Outdoor Advertising and Influencer ProgramJune 10, 2026 | dispatch.comPetVivo (NASDAQ:PETV) Trading Up 0.1% - Still a Buy?June 10, 2026 | americanbankingnews.comPetVivo Holdings, Inc. to Host Virtual Investor EventJune 8, 2026 | globenewswire.comPeer To Peer Network: PTOP's AI Partner Tier 1 AI, Signs Contract With OTCQX:PETV as Enterprise ClientApril 29, 2026 | finanznachrichten.dePTOP’s AI Partner Tier 1 AI, Signs Contract With OTCQX:PETV as Enterprise ClientApril 29, 2026 | usatoday.comPetVivo Holdings, Inc. to Present at the Market Movers Investor SummitApril 21, 2026 | newsfilecorp.comNPETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN LEXINGTON, KENTUCKYMarch 19, 2026 | cincinnati.comCPetVivo Holdings: Balancing Ambitious Growth with Financial RealityFebruary 23, 2026 | newscase.comNPetVivo Holdings Inc (PETV) Q3 2026 Earnings Call Highlights: Strategic Partnerships and AI ...February 19, 2026 | finance.yahoo.comPetVivo Holdings, Inc.: PetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026February 18, 2026 | finanznachrichten.dePetVivo Holdings, Inc. (OTC:PETV) Q3 2026 earnings call transcriptFebruary 18, 2026 | msn.comPetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026February 18, 2026 | finance.yahoo.comPetVivo Holdings, Inc. (PETV) Q3 2026 Earnings Call TranscriptFebruary 17, 2026 | seekingalpha.comPETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 2026 OCALA EQUINE CONFERENCE IN OCALA, FLORIDAFebruary 15, 2026 | azcentral.comAPetVivo Issues Correction and Replacement Press Release; Sets Fiscal Third Quarter 2026 Conference Call for Tuesday, February 17, 2026 at 5:00 p.m. ETFebruary 10, 2026 | globenewswire.comPetVivo Sets Fiscal Third Quarter 2026 Conference Call for Monday, February 16, 2026 at 5:00 p.m. ETFebruary 9, 2026 | globenewswire.comPetVivo Holdings, Inc. Announces Health Canada Acknowledgement of Spryng® as a Veterinary Medical DeviceJanuary 21, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOBLN, HSAQ, NSPR, and PETV Company DescriptionsHealth Sciences Acquisitions Co. 2 NASDAQ:HSAQ$3.85 -0.12 (-3.02%) As of 06/16/2026Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.InspireMD NYSE:NSPR$0.74 +0.03 (+3.59%) Closing price 06/17/2026 04:00 PM EasternExtended Trading$0.74 +0.00 (+0.41%) As of 08:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.Obalon Therapeutics NASDAQ:OBLNObalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.PetVivo NASDAQ:PETV$0.80 -0.05 (-6.00%) As of 06/17/2026 11:23 AM EasternPetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave Insider Sales Look Big, But Should Investors Worry? Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves Meta and Cloud Computing: Real Potential, or a Shot in the Dark? Gravity Check: Houston, SpaceX Has a Valuation Problem Okta’s AI Moment May Be Bigger Than Investors Realize Fox Captures The Living Room With $22B Roku Buy Dave & Buster’s Q1 Miss Raises the Stakes for Its Turnaround Plan Microsoft’s Xbox Problem Is Bigger Than a Console War Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
